Volunteer Assignments and Opportunities: Difference between revisions
No edit summary |
Snehal.Patel (talk | contribs) No edit summary |
||
| (4 intermediate revisions by 3 users not shown) | |||
| Line 834: | Line 834: | ||
| | | | ||
|- | |- | ||
| B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease|| | | B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified||Disease||Holli Drendel | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||YA | | ||YA | ||
| | | | ||
| Line 844: | Line 844: | ||
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 | |B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4 | ||
|Disease | |Disease | ||
|Diana Rush | |||
| | | | ||
| | | | ||
| | |PENDING | ||
| | | | ||
|YA | |YA | ||
| Line 855: | Line 855: | ||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 | |B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6 | ||
|Disease | |Disease | ||
|Celeste Eno | |||
| | | | ||
| | | | ||
| | |PENDING | ||
| | | | ||
|YA | |YA | ||
| Line 866: | Line 866: | ||
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements | |B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements | ||
|Disease | |Disease | ||
| | |Marilena Melas | ||
| | | | ||
| | | | ||
| Line 899: | Line 899: | ||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) | |B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11) | ||
|Disease | |Disease | ||
|Alaa Koleilat | |||
| | | | ||
| | | | ||
| | |PENDING | ||
| | | | ||
|YA | |YA | ||
| Line 908: | Line 908: | ||
|NON-WHO ENTITY | |NON-WHO ENTITY | ||
|- | |- | ||
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| | |'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||YA | | ||YA | ||
| | | | ||
| | | | ||
|- | |- | ||
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| | |Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||YA | | ||YA | ||
| | | | ||
| | | | ||
|- | |- | ||
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| | |NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang | ||
| | | | ||
| | | | ||
|PENDING | |||
| ||YA | | ||YA | ||
| | | | ||
| Line 948: | Line 948: | ||
| | | | ||
|- | |- | ||
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| | |Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 957: | Line 957: | ||
| | | | ||
|- | |- | ||
| Monoclonal B-cell Lymphocytosis||Disease|| | | Monoclonal B-cell Lymphocytosis||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 966: | Line 966: | ||
| | | | ||
|- | |- | ||
|B-cell Prolymphocytic Leukemia||Disease|| | |B-cell Prolymphocytic Leukemia||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 1,020: | Line 1,020: | ||
| | | | ||
|- | |- | ||
|Lymphoplasmacytic Lymphoma||Disease|| | |Lymphoplasmacytic Lymphoma||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 1,029: | Line 1,029: | ||
| | | | ||
|- | |- | ||
| Waldenstrom Macroglobulinemia||Disease|| | | Waldenstrom Macroglobulinemia||Disease|| | ||
| | |||
| | | | ||
| | | | ||
| | | | ||
|SP | |SP | ||
| Line 1,065: | Line 1,065: | ||
| | | | ||
| | | | ||
| | |Complete | ||
| ||SP | |5/26/2021||SP | ||
| | | | ||
| | | | ||
| Line 1,183: | Line 1,183: | ||
| | | | ||
| | | | ||
| | |Complete | ||
| ||SP | |5/28/2021||SP | ||
| | | | ||
| | | | ||
| Line 1,245: | Line 1,245: | ||
| | | | ||
|9/30/20 | |9/30/20 | ||
| | |Complete | ||
| ||SP | |5/26/2021||SP | ||
| | | | ||
| | | | ||